Wright Medical wants to make you aware that Medicare is significantly increasing inpatient hospital reimbursement for total ankle replacement (TAR) and revision of TAR procedures effective October 1, 2017. This 55% reimbursement increase – almost $7,000 – is intended to better align Medicare payment to hospital costs and ensure Medicare beneficiary access to these important ankle surgery procedures.
We are providing key details about the new TAR payment below. As a strong advocate for this policy change, we would be happy to provide any other information your hospital needs as you prepare for this important reimbursement update.
Current Medicare Payment for TAR Procedures
All Medicare lower extremity total joint replacement procedures are currently assigned to the same Medicare severity diagnosis-related group (MS-DRG) for payment purposes, even though TAR procedures are more complex and involve greater resources than total hip and total knee replacement procedures. Specifically, TAR and other total joint replacement procedures track to either MS-DRG 469 or 470 (Major Joint Replacement or Reattachment of Lower Extremity with and without major complication or comorbidity (MCC), respectively).
Almost all TAR procedures (and revision of TAR procedures) track to MS-DRG 470, which has a fiscal year (FY) 2017 payment of $12,326.1 Wright on several occasions has submitted comments to the Centers for Medicare & Medicaid Services (CMS), presenting data showing that TAR procedures are more costly for hospitals than other types of joint replacement procedures. We have requested that CMS revise the MS-DRG / payment assignment for TAR procedures to more accurately compensate hospitals for the costs of performing these procedures.
CMS Significantly Improves Medicare Hospital TAR Payment Beginning October 1, 2017
On August 14, 2017, CMS published its final rule to update the Medicare acute hospital inpatient prospective payment system (IPPS) for FY 2018. 2 As Wright recommended, CMS agreed to assign all TAR procedure cases3 to MS-DRG 469, even when there is no MCC reported.
CMS determined that assignment of all TAR procedures including revisions would more accurately account for hospital resources/costs associated with performing these surgeries than the current framework.
The FY 2018 rate change applies only to Medicare acute hospital/IPPS cases. Note that in some cases, private/commercial insurance plans base payment on Medicare rates. Specific private payer reimbursement varies by payer/contract.
About Wright Medical
Wright is a focused, specialty orthopaedic company that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients’ lifestyles. We are a recognized leader of surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics (synthetic and tissue-based bone graft substitute materials) markets. Wright is committed to finding and delivering the best possible solutions to patients, providers, and Medicare.
We would be pleased to help your hospital understand the new Medicare policy and answer any questions you may have. For questions or for more information, please email [email protected].
This information is presented for informational purposes only and is accurate as of its date of publication. It is the provider’s responsibility to report the codes that accurately describe the products and services furnished to individual patients. Providers should contact the appropriate payer if they have questions and follow the payer’s billing guidelines.